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Summary
Target of rapamycin complex 1 (TORC1) is implicated in growth
control and aging from yeast to humans. Fission yeast is
emerging as a popular model organism to study TOR signaling,
although rapamycin has been thought to not affect cell growth in
this organism. Here, we analyzed the effects of rapamycin and
caffeine, singly and combined, on multiple cellular processes in
fission yeast. The two drugs led to diverse and specific pheno-
types that depended on TORC1 inhibition, including prolonged
chronological lifespan, inhibition of global translation, inhibition
of cell growth and division, and reprograming of global gene
expression mimicking nitrogen starvation. Rapamycin and caf-
feine differentially affected these various TORC1-dependent
processes. Combined drug treatment augmented most pheno-
types and effectively blocked cell growth. Rapamycin showed a
much more subtle effect on global translation than did caffeine,
while both drugs were effective in prolonging chronological
lifespan. Rapamycin and caffeine did not affect the lifespan via
the pH of the growth media. Rapamycin prolonged the lifespan
of nongrowing cells only when applied during the growth phase
but not when applied after cells had stopped proliferation. The
doses of rapamycin and caffeine strongly correlated with growth
inhibition and with lifespan extension. This comprehensive
analysis will inform future studies into TORC1 function and
cellular aging in fission yeast and beyond.
Key words: cell proliferation; chronological aging; gene reg-
ulation; Schizosaccharomyces pombe; Target of Rapamycin;
translation.
Introduction
Budding yeast (Saccharomyces cerevisiae) has been instrumental in
the elucidation of basic mechanisms of cellular aging. Chronological
lifespan (CLS), defined as the time yeast cells survive in a nondividing
state, helps to understand the postmitotic aging of somatic cells
(Fontana et al., 2010; Kaeberlein, 2010). Fission yeast (Schizosac-
charomyces pombe) is only distantly related to budding yeast and
thus provides a valuable complementary model system. Conserved
nutrient-signaling pathways, such as Target of Rapamycin (TOR),
affect aging from yeast to mammals (Laplante & Sabatini, 2012).
Target of Rapamycin proteins are serine/threonine kinases that
control eukaryotic cell growth in response to nutrients (Wullschleger
et al., 2006). In mammalian cells, a single TOR kinase is associated
with two TOR-containing complexes, TORC1 and TORC2. Fission
yeast contains two TOR kinases, Tor1p and Tor2p. Tor2p is essential
and is mainly associated with TORC1 which positively regulates
protein synthesis, metabolism, and transcription (Alvarez & Moreno,
2006; Uritani et al., 2006). Tor1p is associated with TORC2 which is
implicated in DNA damage, telomere length, gene silencing, and
stress response (Weisman, 2010). TORC1 promotes vegetative cell
proliferation and inhibits nitrogen-starvation responses such as sexual
differentiation and amino acid uptake, while TORC2 has opposite
roles in these processes (Wullschleger et al., 2006; Weisman, 2010;
Ikai et al., 2011). Disruption of TORC1, or depletion of Tor2p kinase,
results in phenotypes similar to that of wild-type cells deprived of
nitrogen, suggesting that TORC1 regulates growth in response to
nitrogen availability (Matsuo et al., 2007; Weisman, 2010).
In several organisms, TOR can be inhibited by rapamycin, a
macrolide which initially gained attention owing to its broad, anti-
proliferative properties. Rapamycin forms an intracellular complex
with the isomerase FKBP12 that then binds to the TOR kinase
(Wullschleger et al., 2006). Rapamycin shows a strong inhibitory
effect on vegetative growth in budding yeast (Heitman et al., 1991;
Koltin et al., 1991). Although fission yeast contains a functional
ortholog of FKBP12, Fkh1p (Weisman et al., 2001; Ikai et al., 2011),
the effects of rapamycin in this organism are somewhat confusing. It
has been reported that rapamycin does not affect growth (Weis-
man, 2010), although recent data show that S. pombe TORC1 is
sensitive to rapamycin (Takahara & Maeda, 2012), and high doses
commit cells to mitotic entry (Petersen & Nurse, 2007).
A fundamental function of TORC1 signaling is to promote protein
synthesis by regulating the phosphorylation of the eIF4E-binding
protein (4E-BP1) and the ribosomal S6 kinases (Huang & Manning,
2008). TOR signaling, and particularly TORC1, also plays a pro-aging
role in all organisms tested. In budding yeast, for example, deletion of
TOR pathway genes or treatment with rapamycin prolongs the CLS
(Powers et al., 2006). A role for TOR in lifespan has been confirmed
inmetazoa: worms, flies, andmice treated with rapamycin live longer
than untreated controls (Laplante & Sabatini, 2012). The conserva-
tion of the TOR kinases and their role in aging suggests that
rapamycin could represent the first drug that prolongs the lifespan in
multiple species. In fission yeast, TOR signaling has not been linked to
cellular aging, but S. pombe TORC1 controls the phosphorylation
status of the S6 ribosomal subunits (Nakashima et al., 2010).
Target of Rapamycin proteins belong to the phosphatidylinositol
kinase-related kinase family (PIKK). PIKKs can also be inhibited to
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varying degrees by caffeine that preferentially inhibits mammalian
TOR in vivo (Sarkaria et al., 1999; Block et al., 2004), and it
specifically targets TORC1 in budding yeast (Wanke et al., 2008). In
fission yeast, caffeine sensitivity has been implicated in diverse
cellular processes, including oxidative stress response, the calcineu-
rin pathway, as well as cell morphology and chromatin remodeling
(Calvo et al., 2009). Caffeine extends lifespan in budding yeast
(Wanke et al., 2008) and worms (Lublin et al., 2011). Moreover,
emerging evidence suggests that caffeine affects the healthspan of
organisms and elicits broad beneficial effects. Caffeine elicits a
neuroprotective function that might prevent age-related cognitive
decline and neuron pathology in Parkinson’s disease (Rosso et al.,
2008). Caffeine also prevents age-associated recognition memory
decline in old mice (Costa et al., 2008) and ameliorates pathological
traits that are observed in a transgenic model of proteotoxicity
associated with Alzheimer’s disease (Lublin et al., 2011).
Here, we report specific effects of rapamycin and caffeine, singly
and combined, on CLS, gene expression signatures, protein trans-
lation, and cell proliferation in fission yeast. The two drugs
differentially affect the different cellular processes in a TORC1-
dependent manner, and combined drug treatment often enhances
the resulting phenotypes. These findings afford insight into TORC1
function and cellular aging, and they provide a basis to further
analyze these fundamental processes.
Results
Rapamycin and caffeine prolong chronological lifespan by
TORC1 inhibition
Given the effects of TOR inhibition on lifespan in other organisms,
we examined whether rapamycin and caffeine affect cellular aging
in S. pombe. We also combined caffeine and rapamycin to
maximize TORC1 inhibition (Takahara & Maeda, 2012). Old cells
in stationary phase show an overall shrunken phenotype and
oversized vacuoles (Roux et al., 2009). Compared to untreated
control cells, these aging phenotypes appeared much less pro-
nounced in cells treated with caffeine, rapamycin, or a combination
of the two drugs (Fig. 1A). In addition, the drug-treated cells
exhibited a lower proportion of phloxin B staining than control cells,
indicating decreased cell death (Fig. 1B). Thus, rapamycin and
caffeine seem to delay the aging and death of fission yeast cells.
Accordingly, the drug-treated cells in rich media also showed
substantially prolonged CLS in both rich medium (Figs 1C, S1A) and
minimal medium (Figs 1D, S1B). In rich medium, treatment with
rapamycin alone did lead to slightly longer maximal lifespan (Fig.
S1A), but not median lifespan (Fig. 1C), than did combined drug
treatment, although no such effect was observed in minimal
medium (Figs 1D, S1B). In any case, rapamycin led to a stronger
maximal CLS extension than did caffeine.
Acidification of the media due to the production of acetic acid
has been shown to play a role in limiting the CLS of budding yeast
(Murakami et al., 2011). Although acetic acid in fission yeast
stationary phase cultures is believed to not affect cell survival (Zuin
et al., 2010), caffeine and rapamycin might influence the pH of the
media or enhance the resistance to acidification. We therefore
measured, in parallel, cell growth and pH in media with and without
the addition of caffeine or rapamycin. The drug-treated cell cultures
showed similar patterns of acidification as nontreated cultures, with
the pH dropping to around 5.8–6.0 during entry into stationary
phase (Fig. S2A,B). In addition, we assessed the CLS in phosphate-
citrate-buffered medium at both pH 6.0 and pH 4.0 (Fig. S2C,D).
This analysis showed that the CLS was not affected by the different
pH values in the buffered media. Moreover, caffeine and rapamycin
did extend the CLS in both buffered media as it did in the
nonbuffered media (Fig. S2C,D). We therefore conclude that
caffeine and rapamycin do not affect the CLS via the pH of the
media under the conditions analyzed.
Rapamycin has been reported to interfere with TOR signaling by
binding to the FKBP12 isomerase, called Fkh1p in S. pombe
(Weisman et al., 2001; Weisman, 2010; Ikai et al., 2011). Notably,
unlike caffeine, rapamycin did not extend the CLS in a fkh1 deletion
mutant (fkh1D) (Fig. 2A). This result suggests that rapamycin, but
not caffeine, acts through Fkh1p to inhibit TOR signaling and extend
lifespan. However, this finding was somewhat confounded as fkh1D
cells were themselves more short-lived than wild-type cells (Fig. 2A),
probably due to the lack of Fkh1p isomerase function that is
independent of TOR signaling. To further test whether rapamycin
and caffeine extend lifespan through TORC1 inhibition, we exam-
ined the CLS of tco89D mutant cells that lack a nonessential core
component of TORC1 (Ikai et al., 2011). The tco89D cells were
long-lived compared to wild-type cells, and their CLS was not
further extended by rapamycin or caffeine treatment (Fig. 2B).
These data further suggest that interference with TORC1 signaling
leads to extended lifespan and that rapamycin, and probably also
caffeine, affects the CLS by targeting TORC1. Accordingly, rapa-
mycin extended CLS only when applied to growing cells, when
TORC1 is active, and it did not affect lifespan when applied after
cells had stopped to grow and entered stationary phase (Fig. 2C).
This result shows that rapamycin acts during cell proliferation to
subsequently prolong lifespan in nongrowing cells.
To check whether TORC2 might also affect CLS, independently of
TORC1, we examined the lifespan of a tor1D mutant lacking the
Tor1p component of TORC2 (Hartmuth & Petersen, 2009; Ikai et al.,
2011). The tor1D cells showed a shortened CLS similar to fkh1D cells
(Fig. 2D). Unlike fkh1D and tco89D cells, however, tor1D cells
showed an extended lifespan after treatment with either rapamycin
or caffeine, resulting in a CLS similar to wild-type cells (Fig. 2D).
Thus, the drugs do not target TORC2 to increase the CLS. Taken
together, these data indicate that TORC1 and TORC2 play antag-
onistic roles in shortening and extending the CLS, respectively, and
that the lifespan extension of nongrowing cells by rapamycin and
caffeine is mediated through inhibition of TORC1 signaling while the
cells are still growing.
Rapamycin and caffeine inhibit global translation mediated
by S6 kinase
The TORC1 pathway promotes protein translation, which is mediated
in part via phosphorylation of ribosomal S6 proteins by S6 kinases
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Fig. 1 Rapamycin and caffeine reduce
cellular aging and increase lifespan.
(A) Fission yeast cells after 4 days in
stationary phase in YES with different drug
treatments as indicated. Bar equals 20 lm.
(B) Phloxin B staining of cells after 2 days in
stationary phase in YES with the different
drug treatments. Percentages of red-
stained (dead) cells are indicated at bottom
left. Bar equals 30 lm.(C) Survival curves of
wild-type cells in YES media with or without
drug treatment as indicated.(D) Survival
curves of wild-type cells in EMM media with
or without drug treatment as indicated.
Caffeine and rapamycin are used at
concentrations of 10 mM and
100 lg mL1, respectively.
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Fig. 2 Lifespan extension via caffeine and
rapamycin is TORC1-dependent. All CLS
assays were performed in YES media at
concentrations of 10 mM and 100 lg mL1
of caffeine and rapamycin, respectively. (A)
Survival curves of wild-type and fkh1D cells
with or without rapamycin treatment as
indicated. (B) Survival curves of wild-type
and tco89D cells with or without rapamycin
treatment as indicated. (C) Survival curves
of wild-type cells with or without
rapamycin treatment during growth or
stationary phase as indicated. (D) Survival
curves of wild-type and tor1D cells media
with or without rapamycin treatment as
indicated.
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(Urban et al., 2007; Wei et al., 2008; Nakashima et al., 2010). In
S. pombe, candidates for such S6 kinases are Sck1p, Sck2p, Gad8p
and Psk1p and two ribosomal S6 proteins have been identified,
Rps601p and Rps602p (Nakashima et al., 2010). To test whether the
effects of rapamycin and caffeine on cellular aging are mediated via
S6 kinases, we used an anti-PAS [Phospho (S/T)-Akt substrate]
antibody that detects the phosphorylated forms of S6 proteins. Cells
treated with rapamycin, caffeine, or a combination of both drugs
showed substantially decreased S6 protein phosphorylation, similar
to nitrogen-starved cells (Fig. 3A). Caffeine, alone or combined with
rapamycin, resulted in the strongest depletion of S6 protein
phosphorylation, while partial phosphorylation was maintained in
rapamycin-treated cells. We conclude that caffeine and rapamycin
inhibit the TORC1-regulated phosphorylation by S6 kinases.
We tested whether rapamycin and caffeine also affect TORC2
function, which phosphorylates the S6 kinase-related Gad8p (Ikeda
et al., 2008). We did not detect any decrease in either the
phosphorylation or the protein levels of Gad8p in drug-treated cells
compared to control cells; on the contrary, drug treatment resulted
in a slight decrease in nonphosphorylated Gad8p (Fig. 3B). As a
control, nitrogen availability did not affect the phosphorylation
status or protein levels of Gad8p (Fig. 3B), as expected because
TORC2 signaling is not affected by nitrogen (Nakashima et al.,
2010; Ikai et al., 2011). Thus, while TORC1 function is inhibited by
rapamycin and caffeine, TORC2 seems to become more active by
the drug action. This result is consistent with the lifespan data
(Fig. 2) and with the antagonistic roles played by the two TOR
complexes in S. pombe (Weisman, 2010).
To test whether the inhibition of S6 protein phosphorylation by
rapamycin and caffeine affects protein translation, we analyzed
polysome profiles. Monosome and polysome peaks as well as
polysome-to-monosome (P/M) ratios were determined in drug-
treated and control cells as an estimate for global translational
activity (Fig. 3C). Compared to untreated control cells, the P/M ratio
decreased ~2-fold in caffeine-treated cells and ~3.6-fold in cells
treated with both drugs, while rapamycin alone showed only a
subtle effect (Fig. 3C). The mild effect of rapamycin on global
translation is consistent with the finding that some S6 protein
phosphorylation remained after rapamycin treatment (Fig. 3A).
Taken together, we conclude that caffeine leads to a global
reduction in protein translation by inhibition of TORC1-mediated S6
protein phosphorylation, and that this inhibition is augmented when
combined with rapamycin.
Rapamycin and caffeine trigger gene expression
reprograming similar to nitrogen deprivation and tor2
mutant
To further analyze the effects of rapamycin and caffeine treatment in
S. pombe, we performed gene expression profiling using DNA
microarrays. Rapamycin treatment only led to subtle effects on gene
expression, unless a poor nitrogen source was used (data not
shown). Caffeine, however, triggered a large expression response,
including hundreds of up- and down-regulated genes (Fig. 4A). This
response was further enhanced by combined treatment with
caffeine and rapamycin. Notably, the gene expression signature of
drug-treated cells was highly similar to the signature of cells deprived
of nitrogen (Fig. 4A) (Mata & B€ahler, 2006). Accordingly, the drugs
led to >3-fold down-regulation of 350 genes for ribosomal proteins
and other translation- and growth-related proteins, and >3-fold up-
regulation of 343 genes involved in meiotic differentiation (Mata
et al., 2002) and core environmental stress response (Chen et al.,
2003), including autophagy, membrane transport, and amino acid
(A) (B)
(C)
Fig. 3 Effects of rapamycin and caffeine on TORC1-mediated translational
control. (A) Western blot showing phosphorylation status of S6 proteins, using
anti-PAS antibody, for cells grown in minimal medium supplemented with nitrogen
(control), 1 h after removing nitrogen (N), 30 min following nitrogen refeeding
(+N), or with different drug treatments as indicated. Rps601p-HA and a-tubulin
were used as loading controls. Caffeine and rapamycin are used at concentrations
of 10 mM and 100 lg mL1, respectively. (B) Western blot showing
phosphorylation status of Gad8p-HA, with conditions as in (A). Phosphorylated
and nonphosphorylated Gad8p are highlighted in blue and red boxes, respectively.
(C) Polysome profiles from cells treated for 30 min in the absence (control) or
presence of different drugs as indicated at left. Monosomal (M) and polysomal
(P) peak areas as well as polysome-to-monosome ratios (P/M) are indicated on top
for each condition.
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permease genes (Table S1). Only 20 genes that were up-regulated
during drug treatment were down-regulated during nitrogen
depletion, including genes involved in amino acid metabolism,
transporters, and noncoding RNAs (Fig. 4A, top; Table S1).
Nitrogen is a major cue for proliferation of S. pombe cells, and
the TORC1 pathway controls gene expression in response to
nitrogen and amino acids (Yanagida, 2009), while inhibition of
TORC1 leads to similar phenotypes as those triggered by nitrogen
deprivation and promotes sexual differentiation (Uritani et al., 2006;
Matsuo et al., 2007). We therefore expected that caffeine leads to
gene expression changes as in cells defective for TORC1 signaling.
Indeed, we found that genes reported to be up-regulated in a tor2
mutant (Matsuo et al., 2007) were also up-regulated in cells treated
with caffeine, either singly or combined with rapamycin (Fig. 4B).
Thus, treatment with caffeine mimics nitrogen deprivation and
TORC1 inhibition at the level of transcriptome regulation.
Upon nitrogen removal, S. pombe cells stop growth and arrest in
G1 phase as quiescent cells, which become stubby and shrink in
volume ~2-fold (Yanagida, 2009). Inhibition of Tor2p function
mimics all of these phenotypes (Uritani et al., 2006; Matsuo et al.,
2007). We therefore examined whether the two drugs also lead to
phenotypes associated with nitrogen deprivation. Addition of
caffeine and rapamycin led to some decrease in cell size, but the
drug-treated cells were not as stubby as nitrogen-starved cells
(Fig. S3). Moreover, the drug-treated cells became arrested in G2
phase of the cell cycle, not in G1 phase like nitrogen-deprived cells
(Fig. S3 and data not shown). As previously described (Wang et al.,
1999), our data also revealed that some caffeine-treated cells
transiently delayed cell division and became multiseptated (Fig. S3).
We conclude that despite triggering gene expression responses
similar to nitrogen-deprived and tor2 mutant cells, treatment with
rapamycin and caffeine does not mimic the quiescent state with
respect to cell morphology and G1 cell-cycle arrest.
Rapamycin and caffeine differentially inhibit cell growth and
division via TORC1
In stark contrast to other organisms, rapamycin does not seem to
arrest cell growth in S. pombe (Weisman, 2010). Given the effects
of rapamycin and caffeine on other TORC1-dependent processes
(Figs 1–4), we re-examined the proliferation of cells treated with the
two drugs. Cells treated with rapamycin showed a similar increase in
cell numbers as untreated control cells, while cells treated with
caffeine showed a much slower increase (Fig. 5A). The latter finding
is consistent with the growth inhibition described at high doses of
caffeine (Calvo et al., 2009). The combined treatment with rapa-
mycin and caffeine seemed to further inhibit cell proliferation
(Fig. 5A).
Themaximal cell densities reached after extended incubation were
also differentially affected by the drugs: after 16 h incubation, cells
treatedwith rapamycin reached the same overall density as untreated
control cells (1.6 9 108 cells per mL), cells treated with caffeine grew
to a density of only 8.7 9 106 per mL, while cells treated with both
drugs failed to proliferate altogether (1.6 9 105 cells per mL). These
effects on cell proliferation largelymirror the differential effects of the
drugs on global translation (Fig. 3C). The number of viable cells did
not decrease, even during extended treatment with both drugs
(Fig. 5B). This finding indicates that caffeine and rapamycin lead to a
reversible growth arrest and does not trigger cell death.
(A)
(B)
Fig. 4 Caffeine triggers gene expression reprograming like nitrogen deprivation
and TORC1 inhibition. (A) Hierarchical clustering analysis with columns
representing experimental timepoints and rows representing 539 genes whose
mRNA levels changed >3-fold after exposure to 10 mM caffeine and 100 lg mL1
rapamycin in at least 1 timepoint, and which were measurable in at least three of
the four conditions shown. Columns 1–3: mRNA expression in cells treated with
caffeine singly or combined with rapamycin after 2-h and 5-h treatment as
indicated, relative to expression in the same cells before treatment (this study).
Columns 4 and 5: mRNA expression after 2 and 5 h of nitrogen starvation as
indicated, relative to expression in the same cells before starvation. Relative
expression levels are color coded as indicated at bottom, with missing data in gray.
(B) Cluster analysis as in (A), showing the expression in caffeine singly or combined
with rapamycin and nitrogen starvation for the 177 genes whose mRNA levels
were induced in tor2 mutants (Matsuo et al., 2007) and produced expression data
in at least 2 of the 4 conditions shown.
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The cell density impacted the growth kinetics: cells incubated at
high density recovered rapidly from drug treatment and started to
grow normally (data not shown), possibly reflecting effective drug
degradation by cellular metabolism. Moreover, some genetic strain
backgrounds showed different kinetics of growth inhibition (data
not shown). To further examine the effect of caffeine and
rapamycin on the growth of S. pombe cells, we analyzed the
growth dynamics of rapidly proliferating cell cultures for 24 h in the
presence or absence of rapamycin and caffeine using a microculture
system. Both rapamycin and caffeine led to delayed growth and
decreased maximal growth rate, and combination of the two drugs
markedly increased these effects (Fig. 5C,D). Although rapamycin
alone did not affect the increase in cell numbers and thus cell-cycle
duration (generation time), within a 5-h window (Fig. 5A), it did
inhibit cell growth (Fig. 5C,D). This discrepancy may be explained by
the smaller size of cells treated with rapamycin (Fig. 5G): these cells
(A) (B)
(C) (D)
(E)
(F)
(G)
Fig. 5 Rapamycin and caffeine inhibit cell
growth and division. All these assays were
performed in YES media, at concentrations
of 10 mM and 100 lg mL1 of caffeine and
rapamycin, respectively. (A) Proliferation of
cells in liquid medium without (control) or
with different drug treatments as indicated.
Error bars represent standard deviations of
4 measurements. (B) Cell viability (colony
forming units) during a 24-h treatment with
both rapamycin and caffeine. Box plots
were generated using 10 measurements for
each timepoint. (C) Growth curves of wild-
type cells in liquid medium without (control)
or with different drug treatments as
indicated. (D) Maximal growth slopes
(relative biomass increase per min) for wild-
type and fkh1D cells without (control) or
with different drug treatments as indicated.
Five repeats were conducted for each
condition. (E) Growth curves of fkh1D cells
in liquid YES medium without (control) or
with different drug treatments as indicated.
(F) Serial dilution of wild-type and fkh1D
cells were spotted on agar plates without
(control) or with different drug treatments
as indicated. Cell colonies are shown after 2
(top) and 4 (bottom) days of incubation.
(G) Cell size at division following rapamycin,
caffeine, or combined drug treatment in
wild-type (wt) and fkh1D and pka1D
mutant cells as indicated.
Effects of TORC1 inhibition in fission yeast, C. Rallis et al.6
ª 2013 The Authors. Aging Cell published by John Wiley & Sons Ltd and The Anatomical Society.
grow more slowly while the duration of the cell cycle is not altered,
resulting in smaller cell size at division.
To investigate the mechanism of drug action on TORC1, we
analyzed the effects of rapamycin and caffeine on growth in the
absence of Fkh1p. In fkh1D cells, rapamycin had no effect on cell
growth (Fig. 5D,E). In contrast, treatment of caffeine, alone or
combined with rapamycin, inhibited cell growth even in fkh1D cells
(Fig. 5D,E). These data support the view that rapamycin affects cell
growth by inhibiting TORC1 via Fkh1p, while caffeine affects
growth by inhibiting TORC1 independently of Fkh1p and/or by
acting on other cellular processes. Qualitatively, the same findings
were obtained when using minimal instead of rich medium (Fig. S4).
The growth inhibition by rapamycin was less evident on solid
media, but caffeine and, even more so, the combined drugs greatly
inhibited colony growth (Fig. 5F). This inhibition was partly depen-
dent on Fkh1p, even for caffeine (Fig. 5F). These differences to the
liquid media experiments might reflect the distinct timelines (days vs
hours) and different physiological conditions in solid vs liquid cultures.
Cell size is tuned to the availability of different nutrients (Turner
et al., 2012), and TOR signaling is involved in the nutrient-dependent
coordination between cell growth and division in S. pombe (Ikai
et al., 2011). We found that cell size at division was somewhat
decreased following rapamycin treatment, and dramatically
decreased after combined drug treatment, but not after treatment
with caffeine alone (Fig. 5G). Notably, fkh1D cells were somewhat
larger than wild-type cells, and they showed no cell size reduction in
response to the combined drug treatment (Fig. 5G). This finding is
consistent with data showing that rapamycin affects cell size via
Fkh1p and TORC1 (Weisman, 2010; Ikai et al., 2011). As protein
kinase A (PKA) signaling has also been implicated in cell size control
(Turner et al., 2012), we examined whether rapamycin and caffeine
might also target PKA. As expected, pka1D mutant cells were
substantially smaller than wild-type cells, but the combined drug
treatment led to an even further decrease to a final cell size similar to
the minimum observed with drug-treated wild-type cells in the same
treatment (Fig. 5G). We conclude that the combination of rapamycin
and caffeine treatment affects cell size independently of PKA, by
inhibiting TORC1 signaling.
Taken together, these data indicate that rapamycin and caffeine
affect S. pombe cell growth and division to different degrees.
Rapamycin slightly reduces cell growth in a TORC1-dependent
manner but does not affect cell division, leading to smaller cells.
Caffeine, on the other hand, reduces both cell growth and division,
but cell size is not affected. Combined treatment of rapamycin and
caffeine greatly inhibits cell growth, leading to highly decreased cell
proliferation and cell size.
Dosage effects of rapamycin and caffeine on cell growth and
lifespan
To examine the relationships between the dose of rapamycin and
caffeine and the resulting CLS extension and cell growth inhibition,
we examined growth patterns and viability of cells treated with a
range of concentrations of the two drugs. The maximal growth rate
of the cells was decreased with increasing concentrations of both
rapamycin and caffeine (Fig. 6A,B). While the rapamycin-dependent
growth inhibition gradually and weakly increased with dose
(Fig. 6A), the caffeine-dependent growth inhibition showed a more
threshold-like effect with strong inhibition above ~2 mM (Fig. 6B).
Caffeine concentrations above 20 mM were lethal to fission yeast
cells (data not shown).
Drug dosage also affected the CLS: cells treated with lower
caffeine and rapamycin concentrations showed less pronounced
increase in lifespan than those treated with higher concentrations
(Fig. 6C and data not shown). We further analyzed the correlation
between viability at different days of the CLS assay as a function of
different doses of rapamycin and caffeine. Increases in both the
rapamycin and caffeine concentrations, especially at the lower end
of the doses tested, showed substantial positive effects on cell
viability, while a saturation effect became evident at higher doses
(Fig. S5). As caffeine was lethal for exponentially growing cultures at
concentrations over 20 mM, it was not possible to determine CLS
above this concentration. The growth inhibitory effect of rapamycin
became saturated at concentrations above ~500 ng mL1, which is
the same concentration resulting in maximal CLS extension. We
conclude that increased concentrations of rapamycin and caffeine
are strongly correlated both with increased growth inhibition and
with lifespan extension.
Discussion
This study presents a detailed analysis of rapamycin and caffeine
effects on fission yeast cells, providing a framework to further study
TOR function and cellular aging in this model organism. Rapamycin
and caffeine led to multiple phenotypes via inhibition of TORC1
signaling: (i) increase in CLS; (ii) inhibition of global translation; (iii)
reprograming of gene expression; and (iv) inhibition of cell prolif-
eration. Rapamycin and caffeine differentially affected these con-
served TORC1-dependent processes, and combination of the two
drugs often augmented the phenotypes. The growth inhibition and
lifespan extension depended on the dosage of both rapamycin and
caffeine, with increased doses leading to increased phenotypic
effects. In contrast to other organisms and as previously observed
(Weisman, 2010), rapamycin did never lead to complete growth
arrest in fission yeast cells, even at high doses. This surprising finding
raises the possibility that rapamycin does not completely inhibit
TORC1 or that TORC1 is dispensable for growth in fission yeast.
Notably, rapamycin did prolong the lifespan of nondividing cells
only when applied while these cells were still growing and dividing
but had no effect when applied after cells reached stationary phase.
This finding could reflect that TORC1 is only active in growing cells,
and reducing this activity ultimately extends the longevity of cells in
stationary phase. This phenomenon is reminiscent of the finding
that low glucose levels during cell growth promote extended
lifespan of stationary phase cells via the PKA pathway (Roux et al.,
2009). The nature of this intriguing information flow from growth
to stationary phase is not clear, however. Rapamycin inhibited
TORC1 activity via the FKBP12 isomerase ortholog Fkh1p. These
findings establish for fission yeast a conserved action of rapamycin
in TORC1 inhibition and longevity. Unlike TORC1 activity, which
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shortens the CLS, TORC2 activity seems to promote the CLS. Thus,
TORC1 and TORC2 may play antagonistic roles with respect to
longevity, as they do with respect to other cellular processes such as
growth and meiotic differentiation (Weisman, 2010).
Unlike in budding yeast where acidification of growth media
plays a role in limiting the CLS (Murakami et al., 2011), we found no
evidence that pH changes are important in fission yeast for the
effects on CLS reported here. Rapamycin and caffeine did not
influence media acidification, and media buffered at two vastly
different pH values had no effect on CLS in untreated cells or on its
extension in drug-treated cells. These findings are consistent with
results reported by Zuin et al. (2010) showing that acetic acid in
fission yeast stationary cultures does not affect cell survival. Note
that even in budding yeast, media acidification does not fully explain
the role of TOR-S6K pathway on aging, because its inhibition still
extends CLS in media that is not acidified and does not contain
acetic acid (Wei et al., 2008).
Caffeine triggers the stress-activated protein kinase (SAPK)
pathway in S. pombe (Zuin et al., 2010). The SAPK and TOR
pathways may be antagonistically regulated (Lopez-Maury et al.,
2008), raising the possibility that inhibition of TORC1 signaling by
caffeine causes the activation of SAPK. Indeed, caffeine treatment
led to induction of stress response genes and repression of ribosomal
and other growth-related genes while Sty1p was required for the
caffeine-induced lifespan extension (Fig. 4). The gene expression
changes observed could cause or support some of the drug-induced
phenotypes such as growth and translational inhibition. We find that
caffeine treatment in sty1D cells decreases rather than increases the
CLS (unpublished data). These data suggest that Sty1p may be
required for the CLS extension imposed by caffeine, as it is for the
CLS extension by calorie restriction (Zuin et al., 2010). Despite
triggering gene expression responses similar to nitrogen-deprived
and tor2mutant cells, treatment with rapamycin and caffeine did not
mimic the quiescent state with respect to cell morphology and G1
cell-cycle arrest (Yanagida, 2009). This finding suggests that repro-
graming of gene expression is not sufficient to trigger a quiescent
state within the 5-h timeframe of our experiment.
Reduced protein translation has been linked to increased lifespan
in several organisms (Harrison et al., 2009; Bjedov et al., 2010;
Kaeberlein, 2010). The effects of rapamycin and caffeine on global
translation are therefore consistent with the increase in CLS caused
by the same drugs. As translation is required for cellular growth, it is
also consistent with the two drugs inhibiting cell proliferation and
with the correlation between slow growth and longevity as a
function of drug concentrations (Figs 6; S5). However, rapamycin
alone was sufficient for a substantial extension in lifespan (Fig. 2),
while it had much more subtle effects on global translation and on
phosphorylation levels of S6 proteins (Fig. 3). This apparent paradox
suggests either that a weak inhibition of translation is more effective
for longevity or that rapamycin can extend lifespan by mechanisms
other than translation. One alternate mechanism could act via
protection from DNA damage and genome instability in stationary
phase; consistent with this idea, rapamycin has recently been shown
to repress the phenotypes of cut1 and cut2 chromosome segrega-
tion mutants, which cause DNA damage (Ikai et al., 2011). In other
organisms, rapamycin positively affects lifespan through elusive
pathways apart from growth and translation (Wei et al., 2008;
Harrison et al., 2009; Bjedov et al., 2010), possibly involving
mitochondrial function (Pan & Shadel, 2009).
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Fig. 6 Rapamycin and caffeine doses correlate with growth inhibition and CLS
extension. All these assays were performed in YES media. (A) Maximal growth
slopes of cells treated with different concentrations of rapamycin as indicated.
Vertical dashed lines indicate the standard concentrations of rapamycin used in the
other assays of the paper. (B) Maximal growth slopes of cells treated with different
concentrations of caffeine as indicated. Note the different scale of the y-axis
compared to (A), indicated by the horizontal red and green dashed lines in (A) and
(B), respectively. Vertical black dashed lines indicate the standard concentration of
caffeine used in the other assays of the paper. (C) Survival curves of wild-type cells
with or without different drug treatments as indicated.
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Fission yeast is bound to make unique contributions to defining
both universal and specialized processes relevant to cellular aging
and TOR signaling; its low-complexity genome, technical resources,
and genetic tractability under tightly controlled conditions provide a
potent platform, complementary to budding yeast, to identify
relevant genetic factors involved in these processes. This study
presents a basis for future mechanistic analyses of TORC1 control
and CLS in fission yeast and will help identify new proteins
functioning in these fundamental processes.
Experimental procedures
Strains and media
Wild-type cells were the 972 h strain. S. pombe deletion mutant
strains, including fkh1D, tco89D and tor1D deletion mutants, were
obtained from the Bioneer version 2.0 (Bioneer Corporation,
Daejeon, Korea) library and PCR-verified for correct deletions at
both junctions. The C-terminally HA-tagged gad8 and rps601 strains
were generated as described (B€ahler et al., 1998). Cell cultures were
grown as indicated in yeast extract plus supplements (YES, 3%
glucose) or EMM medium (2% glucose). Nitrogen deprivation
experiments were performed in EMM without NH4Cl2. Cells were
grown to an OD600 of 0.5, washed twice with EMMwithout NH4Cl2,
and incubated for 1 h in EMM without NH4Cl2, when a sample was
taken (N). Cells were then centrifuged and resuspended in EMM
with NH4Cl2 and incubated for 30 min, when another sample was
taken (refeeding). Liquid cultures were grown at 32 °C with shaking
at 130 rotations per minute.
Caffeine and rapamycin sensitivity and stress assays by serial
dilutions
Schizosaccharomyces pombe strains were rapidly grown in liquid
YES cultures to an OD600 of 0.5. Ten-fold serial dilutions of cells
were spotted, using replica platers for 48-well or 96-well plates
(Sigma-Aldrich Ltd, Gillingham, UK), onto YES agar plates, with or
without caffeine (10 mM) and/or rapamycin (100 ng mL1). Plates
were incubated at 32 °C.
Measurement of cell size at division
Control and drug-treated cells were fixed in 4% formaldehyde for
10 min at room temperature, washed with 50 mM sodium citrate
and 100 mM sodium phosphate, and stained with calcofluor
(50 lg mL1). Cells were photographed in a Zeiss microscope using
the OpenLab program. At least 100 septated cells were counted and
analyzed for each condition using the ImageJ package (Rasband,
1997–2012).
Measurement of cell number during growth
Cell numbers were determined using a Beckman Coulter Counter
system. Four independent dilutions of each culture were prepared
and measured. For growth measurements in caffeine and rapamycin
(Fig. 4), log-phase cultures in YES were separated into the following
four samples: an untreated growth control, a sample supplemented
with 10 mM caffeine (Calvo et al., 2009), a sample treated with
100 ng mL1 rapamycin, and a sample treated with both caffeine
and rapamycin at the doses above. We used 1.5 9 105 cells to
inoculate each culture.
Growth assay
Growth curves under normal and various stress conditions were
automatically determined by the BioLector microfermentation sys-
tem (m2p-biolabs), using 48-well flowerplates, at 1.5 mL volume,
1000 rpm and 32 °C. The growth dynamics, maximum growth
slopes, and maximum densities were calculated using the grofit R
package (Kahm et al., 2010). For caffeine and rapamycin treatments,
rapidly growing cultures at OD600 = 0.5 in YES were diluted at
OD600 = 0.15 and were treated with the drugs at the concentrations
indicated in the corresponding Fig. 5D,E. Same procedure was
followed in Fig. S4, where EMM media were used instead of YES.
Chronological lifespan assay
Cells were grown in YES or EMM as described (Roux et al., 2009).
When cultures reached a stable maximal density, cells were
harvested, serially diluted, and plated on YES plates. The measure-
ment of colony-forming units (CFUs) was taken as timepoint 0 at the
beginning of the CLS curve (i.e., 100% cell survival). Measurements
of CFUs were conducted on the following days until cultures
reached 0.1% of the initial cell survival. Error bars represent
standard deviation calculated from three independent cultures, with
each culture measured at least three times at each timepoint. To
determine the CLS of cells treated with caffeine and/or rapamycin,
cell cultures at OD600 = 0.15 were treated with the drugs at
concentrations indicated in the corresponding figures. Survivals are
indicated in Table S2. Survival curves were statistically analyzed with
Kaplan–Meier survival plots and logrank tests using the survival R
package (http://www.r-project.org/).
Western blotting and antibodies
For protein preparations, cells were diluted in 6 mM Na2HPO4, 4 mM
NaH2PO4.H2O, 1% Nonidet P-40, 150 mM NaCl, 2 mM EDTA,
50 mM NaF supplemented with protease (PMSF) and phosphatase
inhibitors (Sigma cocktails 1 and 2) together with glass beads. Cells
were lysed in a Fastprep-24 machine. Anti-HA (H9658, Sigma) and
anti-a-tubulin (B5-1-2, Sigma) were used at 1/5000, 1/5000 and 1/
10,000 dilutions, respectively. Detection was performed using anti-
mouse and anti-rabbit HRP-conjugated antibodies (1/5000 dilutions)
with the ECL Western blotting detection system (GE Healthcare,
Chalfont St Giles, UK) according to the manufacturer’s protocol.
Polysome profiling
Translational profiles were acquired as previously described (Lackner
et al., 2007). S. pombe cells were grown in liquid YES cultures to
OD600 = 0.5. Caffeine and rapamycin (10 mM and 100 ng mL
1,
respectively) were added alone and in combination. Cells were
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harvested after 30 min of drug treatment. S. pombe protein
preparations were performed according to a standard protocol as
described earlier (western blotting), but using a different lysis buffer
(20 mM Tris–HCl pH 7.5, 50 mM KCL, 10 mM MgCl). Sucrose
gradients (10–50%) were generated using a Biocomp Gradient
Master, and protein preparations were loaded and centrifuged at
35 000 rpm for 2 h 40 min. Polysome gradients were then loaded
to the fractionator to obtain the translational profiles.
Expression microarrays
Cells were grown in EMM to OD600 = 0.5 and harvested. RNA was
isolated followed by cDNA labeling (Lyne et al., 2003). For caffeine
and rapamycin treatments (10 mM and 100 ng mL1, respectively),
rapidly growing cells (OD600 = 0.5) in EMM were treated with the
drugs for 2 and/or 5 h as indicated in Fig. 4. For nitrogen starvation,
rapidly growing cells (OD600 = 0.5) in EMM were washed twice with
EMM without NH4Cl2 and incubated in this medium for 2 and 5 h
before harvesting. Agilent 8 9 15K custom-made S. pombe expres-
sion microarrays were used, and hybridizations and subsequent
washes performed according to the manufacturer’s protocols. The
obtained data were scanned and extracted using GenePix, pro-
cessed using R scripts for quality control and normalization (Lyne
et al., 2003), and analyzed using GeneSpring GX3 (Agilent
Technologies UK Ltd, Wokingham, UK). Two independent biological
repeats with a dye swap were performed. Microarray data have
been submitted to ArrayExpress (accession number E-MTAB-1489).
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